David Cooper has been named senior vice president, finance, and treasurer at Agilent Technologies. Most recently, he was CFO of QRS, a collaborative services and software provider.
Also, former Agilent Technologies CEO Edward Barnholt has been named to the board of directors of EBay. Barnholt stepped down as CEO of Agilent in March.
Acuity Pharmaceuticals said this week that it has formed its scientific advisory board.
Members of the board include Alexander Brucker, professor of ophthalmology at the University of Pennsylvania Scheie Eye Institute; Lloyd Paul Aiello, associate professor of ophthalmology at Harvard Medical School and head of the Section of Eye Research at the Joslin Diabetes Center; Alan Gewirtz, professor of medicine, and pathology, and laboratory medicine at the University of Pennsylvania School of Medicine; Baruch Kuppermann¸ professor of ophthalmology at the University of California, Irvine; Richard McCloskey, vice president of medical technology at Johnson & Johnson Development Corporation; Lawrence Singerman, clinical professor of ophthalmology at Case Western Reserve University School of Medicine and professor of clinical ophthalmology at the Bascom Palmer Eye Institute of the University of Miami; Jason Slakter, vitreoretinal surgeon and macular disease specialist at the Manhattan Eye, Ear, and Throat Hospital and clinical professor of ophthalmology at NYU School of Medicine; William Tasman, chairman of the department of ophthalmology at Jefferson Medical College and ophthalmologist-in-chief of Wills Eye Hospital; Lawrence Yannuzzi, professor of clinical ophthalmology at Columbia University Medical School; and Yihai Cao, professor and team leader of the Microbiology and Tumor Biology Center at the Karolinska Institute.
Additionally, Acuity said that Julia Haller, professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute, has joined the company as clinical consultant and advisor.
Matthew Friel has become senior vice president of corporate development at Fisher scientific, the company said last week. Most recently, he was with GenTek, where he served as executive vice president of finance and business development, as well as vice president and CFO, at GenTek. Friel holds a BS in business administration from
The National Academies of Science this week elected 72 new members and 18 foreign associates. Among them are RNAi pioneer Craig Mello, a Howard Hughes investigator and professor at the University of Massachusetts Medical School in Worcester, and Steven Henikoff, a Howard Hughes investigator and member of the Fred Hutchinson Cancer Research Center, who invented computer strategies and technologies that helped with the sequencing of the human genome.
Timothy Kish has resigned as chief financial officer of Illumina, the company said this week. He will remain a company consultant.
Mark Gardner has been promoted to chief marketing officer of Invitrogen, the company said this week. Most recently, he was Invitrogen's vice president of commercial marketing.
Henk Kocken has become vice president for quality systems of VaxGen, the company said this week. Previously, he was senior director of quality assurance at CoTherix. Prior to that, he held various quality assurance and control positions at InterMune, FibroGen, Bio-Rad Laboratories, and Clontech Laboratories. Kocken holds a PhD in chemical technology from
Vikram Jog has joined XDx as chief financial officer, a new position, the company said this week. Most recently, he was vice president of finance for Celera Genomics and Celera Diagnostics. Prior to this, he was vice president of planning and corporate controller for Applera. Jog received a bachelor of commerce degree from
Joe Donahue has become corporate chief business officer and president of InforSense North
Jim Golden has left his position as vice president of research at IDC's market research unit Life Science Insights to join SAIC as chief technology officer for its commercial life science group, GenomeWeb News' sister publication BioInform reported last week. Golden told BioInform that he will be responsible for adapting technologies that SAIC has developed for its government and public-sector clients to the pharmaceutical IT market.
Anthony Baxter has become CEO of DeltaDot, the London-based company said last week. Prior to that, he was CEO of Argenta Discovery. DeltaDot's first product is a High Performance Capillary Electrophoresis system to analyze candidate drug compounds, either nucleic acid or proteins, with enhanced speed, resolution and improved running costs.
Iain Mattaj took office as director-general of the European Molecular Biology Laboratory on May 1, EMBL said on Sunday. For the last five years, he was EMBL's scientific director.